IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2026)

IM Cannabis' (IMCC) quarterly Total Non-Current Liabilities came in at $805772.3 in Q1 2026, up 19.57% year-on-year from $673918.2 in Q1 2025, and down 16.46% quarter-over-quarter from $964481.1 in Q4 2025.

IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

IM Cannabis' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $805772.3 for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 19.57% year-over-year to $805772.3 in Q1 2026; TTM through Mar 2026 was $805772.3, a 19.57% increase from a year earlier, with the FY2025 full-year figure at $964481.1, up 17.48% from the prior year.
  • Total Non-Current Liabilities declined to $805772.3 in Q1 2026 per IMCC's latest filing, from $964481.1 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $21.8 million in Q1 2022 and bottomed at $673918.2 in Q1 2025.
  • The 5-year median for Total Non-Current Liabilities is $1.7 million (2023), against an average of $4.0 million.
  • Across the five-year window, Total Non-Current Liabilities tumbled 87.88% in 2022 and soared 37.91% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $2.3 million in 2022, then dropped by 26.13% to $1.7 million in 2023, then slumped by 51.68% to $804614.4 in 2024, then grew by 19.87% to $964481.1 in 2025, then decreased by 16.46% to $805772.3 in 2026.
  • Per Business Quant, the three latest IMCC Total Non-Current Liabilities figures stand at $805772.3 (Q1 2026), $964481.1 (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn 805,772.29

Historic Data

Download Data
DateValue
Mar 31, 2026 805,772.29
Dec 31, 2025 964,481.05
Sep 30, 2025 1.14 Mn
Jun 30, 2025 1.34 Mn
Mar 31, 2025 673,918.23
Dec 31, 2024 804,614.43
Sep 30, 2024 862,803.86
Jun 30, 2024 973,879.21
Mar 31, 2024 1.69 Mn
Dec 31, 2023 1.67 Mn
Sep 30, 2023 3.41 Mn
Jun 30, 2023 4.55 Mn
Mar 31, 2023 4.60 Mn
Dec 31, 2022 2.25 Mn
Sep 30, 2022 2.96 Mn
Jun 30, 2022 17.42 Mn
Mar 31, 2022 21.79 Mn
Dec 31, 2021 15.03 Mn
Sep 30, 2021 24.41 Mn
Dec 31, 2020 14.76 Mn